tm logo
REGABATIN
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 16 Apr 2021

Last Applicant/ Owned by

30 Worcester Road

Toronto, Ontario

CA

M9W5X2

Serial Number

86069359 filed on 19th Sep 2013

Registration Number

4603064 registered on 09th Sep 2014

in the Principal Register

Correspondent Address

TORONTO, ONTARIO

M9W5X2

CANADA

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

REGABATIN

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceu Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations


First Use Date in General

04th Nov 2013

First Use Date in Commerce

04th Nov 2013

Class [005]
Pharmaceutical Products


Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis


First Use Date in General

04th Nov 2013

First Use Date in Commerce

04th Nov 2013

Mark Details


Serial Number

No 86069359

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Apr 2021CANCELLED SEC. 8 (6-YR)
09th Sep 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09th Sep 2014REGISTERED-PRINCIPAL REGISTER
05th Aug 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04th Aug 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15th Jul 2014STATEMENT OF USE PROCESSING COMPLETE
15th Jul 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
20th Jun 2014USE AMENDMENT FILED
20th Jun 2014TEAS STATEMENT OF USE RECEIVED
13th May 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT